The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism

Clinica Chimica Acta

Volumn 341, Issue 1-2, 2004, Pages 127-131

  Gürdöl, Figen ^a   Işbilen, Elif ^a   Yilmaz, Hülya ^b   Isbir, Turgay ^b   Dirican, Ahmet ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme; Polymorphism; Preeclampsia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

INSERTION SEQUENCES;

EID: 1142309614     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.11.010     Document Type: Article

References (27)

1. Ehlers R.W.M., Riordan J.F. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry. 28:1989;5311-5317.
2. Rigat B., Hubert C., Alhenc-Gelas M.F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1990;1343-1346.
3. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin-I-converting enzyme (ACE) gene controls plasma ACE levels. Am J. Hum. Genet. 51:1992;197-205.
4. Butler R., Morris A.D., Burchell B., Struthers A. DD angiotensin- converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension. 33:1999;1164-1168.
5. Cambien F., Poiroer O., Lecerf L., Evans A., Cambou J.P., Arvelier D. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
6. Nakai K., Itoh C., Miura Y.et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 90:1994;2199-2202.
7. Perticone F., Ceravolo R., Maio R., Ventura G., Zingone A., Perrotti N. et al. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension. 31:1998;900-905.
8. Jeunemaitre X., Lifton R.P., Hunt S.C., Williams R.R., Lalouel J.M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat. Genet. 19:1992;72-75.
9. Burg M., Mene J., Ostendorf T., Kliem V., Floege J. Gene-polymorphisms of angiotensin-converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. Clin. Nephrol. 48:1997;205-211.
10. Bedir A., Arik N., Adam B., Kilinc K., Gumus T., Guner E. Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension. Am J. Hypertens. 12:1999;1038-1043.
11. Miller S.A., Dykes D.D., Polesky H.S. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1998;1215.
12. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) (dipeptidyl carboxypeptidase I). Nucleic Acids Res. 20:1992;1433.
13. Lindpaintner K., Pfeffer M.A., Kreutz K., Stamfer M.J., Grodstein F., LaMotte F.et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332:1995;706-711.
14. Holmquist B., Bünning P., Riordan J.F. A continuous monitoring spectrophotometric assay for angiotensin converting enzyme. Anal. Biochem. 95:1979;540.
15. Liston W.A., Kilpatrick D.C. Is genetic susceptibility to preeclampsia conferred by homozygosity for the same single recessive gene in mother and fetus? Br. J. Obstet. Gynecol. 25:1991;1079-1086.
16. Zhou N., Yu P., Chen J., Huang H., Jiang S. Detection of insertion/deletion polymorphism of angiotensin converting enzyme gene in preeclampsia. Zhonghua Yixue Zazhi. 16:1996;29-31.
17. Morgan L., Foster F., Hayman R.et al. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and preeclamptic pregnancies. J. Hypertens. 17:1999;765-768.
18. Tamura T., Johanning G.L., Goldenberg G.L., Johnston K.E., DuBard M.B. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet. Gynecol. 88:1996;497-502.
19. Burg M., Mene J., Ostendorf T., Kliem V., Floege J. Gene-polymorphisms of angiotensin-converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. Clin. Nephrol. 48:1997;205-211.
20. Busjhan A., Knoblauch H., Knoblauch M.et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. Hypertension. 29:1997;165-170.
21. Li J., Hu H.Y., Zhao Y.N. Serum angiotensin-converting enzyme activity in pregnancy-induced hypertension. Gynecol. Obstet. Invest. 33:1992;138-141.
22. Lee M.I., Bottoms S.F., Sokol R.J., Todd H.M. Angiotensin converting enzyme activity in hypertensive pregnancy. J. Perinat. Med. 15:1987;258-262.
23. Goldkrand J.W., Fuentes A.M. The relation of angiotensin-converting enzyme to the pregnancy-induced hypertension-preeclampsia syndrome. Am J. Obstet. Gynecol. 1986;792-800.
24. Parente J.V., Franco J.G. Jr., Grene L.J., Meirelles R.S., Martinez A.R. Angiotensin converting enzyme: serum levels during normal pregnancy. Am J. Obstet. Gynecol. 135:1979;586-589.
25. Weir M.R., Dzau V.J. The renin-angiotensin-aldosteron system: a specific target for hypertension management. Am J. Hypertens. 12:1999;205S-213S.
26. Urata H. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265:1990;22348-22357.
27. Guo C., Ju H., Leung D., Massaeli H., Shi M., Rabinovitch M. A novel vascular smooth muscle chymase is upregulated in hypertensive rats. J. Clin. Invest. 107:2001;703-715.